These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20813340)

  • 1. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss.
    Mielke MM; Haughey NJ; Bandaru VV; Schech S; Carrick R; Carlson MC; Mori S; Miller MI; Ceritoglu C; Brown T; Albert M; Lyketsos CG
    Alzheimers Dement; 2010 Sep; 6(5):378-85. PubMed ID: 20813340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of manual and automated determination of hippocampal volumes in MCI and early AD.
    Shen L; Saykin AJ; Kim S; Firpi HA; West JD; Risacher SL; McDonald BC; McHugh TL; Wishart HA; Flashman LA
    Brain Imaging Behav; 2010 Mar; 4(1):86-95. PubMed ID: 20454594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
    J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial.
    Grundman M; Sencakova D; Jack CR; Petersen RC; Kim HT; Schultz A; Weiner MF; DeCarli C; DeKosky ST; van Dyck C; Thomas RG; Thal LJ;
    J Mol Neurosci; 2002; 19(1-2):23-7. PubMed ID: 12212787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
    Xing Y; Tang Y; Zhao L; Wang Q; Qin W; Zhang JL; Jia J
    J Alzheimers Dis; 2016 Apr; 52(3):1029-35. PubMed ID: 27079712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
    Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
    Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.
    Mielke MM; Okonkwo OC; Oishi K; Mori S; Tighe S; Miller MI; Ceritoglu C; Brown T; Albert M; Lyketsos CG
    Alzheimers Dement; 2012; 8(2):105-13. PubMed ID: 22404852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies.
    Shi F; Liu B; Zhou Y; Yu C; Jiang T
    Hippocampus; 2009 Nov; 19(11):1055-64. PubMed ID: 19309039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Alzheimer's disease using a hypometabolic convergence index.
    Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Bandy D; Alexander GE; Thompson PM; Shaw L; Trojanowski JQ; Jack CR; Landau SM; Foster NL; Harvey DJ; Weiner MW; Koeppe RA; Jagust WJ; Reiman EM;
    Neuroimage; 2011 May; 56(1):52-60. PubMed ID: 21276856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.
    Kim M; Nevado-Holgado A; Whiley L; Snowden SG; Soininen H; Kloszewska I; Mecocci P; Tsolaki M; Vellas B; Thambisetty M; Dobson RJB; Powell JF; Lupton MK; Simmons A; Velayudhan L; Lovestone S; Proitsi P; Legido-Quigley C
    J Alzheimers Dis; 2017; 60(3):809-817. PubMed ID: 27911300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
    Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
    Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
    Jack CR; Petersen RC; Xu YC; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Waring SC; Tangalos EG; Kokmen E
    Neurology; 1999 Apr; 52(7):1397-403. PubMed ID: 10227624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.